There is renewed hope this week of an effective treatment for Alzheimers. The US pharmaceutical giant Eli Lilly has announced its experimental Alzheimer's drug slowed cognitive by 35 percent compared to a placebo. FRANCE 24's Leo McGuinn tells us more.
